- Home
- VKTX vs RYN Comparison
VKTX vs RYN Comparison
Compare VKTX & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VKTX | RYN |
|---|---|---|
| Founded | 2012 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.3B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | VKTX | RYN |
|---|---|---|
| Price | $34.04 | $24.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | ★ $87.07 | $27.00 |
| AVG Volume (30 Days) | ★ 3.3M | 1.8M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 11.72% |
| EPS Growth | N/A | ★ 373.89 |
| EPS | N/A | ★ 5.07 |
| Revenue | N/A | ★ $1,293,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.65 |
| Revenue Growth | N/A | ★ 60.70 |
| 52 Week Low | $18.92 | $21.06 |
| 52 Week High | $43.15 | $28.31 |
Technical Indicators
Market Signals| Indicator | VKTX | RYN |
|---|---|---|
| Relative Strength Index (RSI) | 49.82 | 72.06 |
| Support Level | $29.54 | $22.93 |
| Resistance Level | $36.00 | $23.60 |
| Average True Range (ATR) | 1.98 | 0.60 |
| MACD | -0.02 | 0.31 |
| Stochastic Oscillator | 59.83 | 97.95 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About RYN Rayonier Inc. REIT
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.